Status:
COMPLETED
A Clinical Trial of the Vessel Sealing System (LigaSure) in Azygoportal Disconnection and Splenectomy in Patients With Portal Hypertension
Lead Sponsor:
Shanghai Changzheng Hospital
Conditions:
Liver Cirrhosis
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
The aim of this trial was to verify the efficiency of a new surgical device (the LigaSure vessels sealing system) in esophagogastric decongestion and splenectomy in patients with portal hypertension.
Detailed Description
Bleeding from esophageal and gastric cardia varices is the major life threatening complication in patients with portal hypertension. Patients with portal hypertension have a mortality rate of 30%-50% ...
Eligibility Criteria
Inclusion
- Patients with liver cirrhosis accompanied by portal hypertension and secondary hypersplenism due to hepatitis, alcoholic cirrhosis or schistosomiasis, who undergoing elective azygoportal disconnection and splenectomy
Exclusion
- Liver function as Child-Pugh C
- Hemoglobin \< 9 g/dL
- Ascites
- Abnormal coagulation
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00965744
Start Date
January 1 2006
End Date
December 1 2008
Last Update
August 27 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of General Surgery, Shanghai Chang Zheng Hospital
Shanghai, Shanghai Municipality, China, 200003